Megan Matthews
Megan Matthews is an assistant professor in Penn's Department of Chemistry and a researcher who contributed to the study revealing the mechanism by which hydralazine inhibits the enzyme ADO, offering insights that could lead to innovative cancer therapies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 7.00 | 0.04% | +0% | 331,002,651 | 146,786 | $21,000,000 | 9,313$ |
| Hungary | 1 | 7.00 | 0.10% | +0% | 9,660,351 | 9,798 | $160,000 | 162$ |
| Totals | 2 | 340,663,002 | 156,584 | $21,160,000 | 9,475$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Hungary:
Megan Matthews, a researcher at the University of Pennsylvania, noted that preeclampsia disproportionately affects Black mothers in the United States.
7
United States:
Megan Matthews, an assistant professor in Penn's Department of Chemistry and a researcher in the study, stated in the same press release.
7